Multi-Omic, Clinomic and Digitomic Attributes of Major Depression for Integrative Analytics

Part of paid clinical trials in Jacksonville, Florida.

Sponsor
Mayo Clinic
Study ID
NCT05910957
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
20 Years - 62 Years
Healthy Volunteers
Not accepted

Study Details

The purpose of this research is to see if information from blood and data from smartwatches can be combined to help diagnose depression and determine if transitions between active depression and treated depression can be predicted.

Key Dates

Start date
Aug 2, 2023
Status verified
Jul 2025
Primary completion
Jun 6, 2026
Completion
Dec 6, 2026

Study Design

Enrollment
40 participants (estimated)

Arms

  • Arm: Non-depressed controls
    Subjects without depression will fill out questionnaires about their general health and wellbeing, quality of life, mental health, emotional health, suicide risk, support system, and childhood experiences. Smartwatch data will also be collected to monitor step count, sleep quality, heart rate (resting and active), and activity rates.
  • Arm: Antidepressant-treated adults
    Subjects diagnosed with depression will fill out questionnaires about their general health and wellbeing, quality of life, mental health, emotional health, suicide risk, support system, and childhood experiences. Smartwatch data will also be collected to monitor step count, sleep quality, heart rate (resting and active), and activity rates.

Primary Outcome Measure

Change in Quick Inventory of Depressive Symptoms-Clinician Rated (QIDS-CR) scale [ Time Frame: Baseline, 4 weeks, and 8 weeks ]

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic FloridaJacksonvilleFlorida32224-

Find similar trials in Jacksonville, FL

By condition
Depression
By specialty
PsychiatryMental healthBehavioral health
By research site
Mayo Clinic Florida· Jacksonville, FL

Related Studies